Artificial intelligence has transformed nearly every conversation in radiology. Yet much of the industry's focus remains on what happens after an image is acquired: detection algorithms, reporting tools, workflow prioritization, and diagnostic support.
According to Ohad Arazi, CEO of Subtle Medical, some of the greatest opportunities for innovation may exist much earlier in the imaging process.
In this episode of The Radiology Report Podcast, host Daniel Arnold sat down with Arazi to discuss his journey through medical imaging, the evolution of AI in radiology, and why improving image acquisition could be one of the most impactful ways to improve patient care, operational efficiency, and radiologist workflows.
About Ohad Arazi
Ohad has enjoyed a dynamic 20-year career as an entrepreneur, investor, public company executive and CEO in the digital health and medical technology space, involved in multiple exits to strategic acquirers. Prior to joining Subtle in April 2026, he most recently served as CEO and President of Clarius, an award-winning portable ultrasound and AI company, which was recognized by Fast Company as one of the world's most innovative companies in 2023. Ohad led Clarius to profitability and scale, with over 35,000 systems sold in 70 countries.
Before his time at Clarius, Ohad served as CEO for Zebra Medical Vision, venture-backed imaging AI start-up (successful exit in 2022), as Executive Chair of Genoox (successful exit 2025), as Chief Strategy Officer for TELUS Health, and had an 11-year tenure as the SVP & GM for McKesson/Change Healthcare's PACS business.
